Biomechanical factors and macrophages in plaque stability

Cardiovascular Research

Volumn 99, Issue 2, 2013, Pages 284-293

  Seneviratne, Anusha ^a   Hulsmans, Maarten ^b   Holvoet, Paul ^b   Monaco, Claudia ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Inflammation; Macrophages; microRNAs; Plaque rupture; Shear stress

Indexed keywords

ABC TRANSPORTER A1; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR1; COLLAGENASE 3; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 23; MICRORNA; MICRORNA 155; MICRORNA 20A; MICRORNA 222; MICRORNA 9; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PADGEM PROTEIN; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; ARTERY; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOMECHANICS; CELL ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL EXPANSION; CELL MATURATION; CELL PROLIFERATION; CELL SURFACE; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FOAM CELL; HEART INFARCTION; HUMAN; IMMUNOPHENOTYPING; INFLAMMATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; MECHANICAL STRESS; MECHANORECEPTOR; MEDIATOR; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION;

INFLAMMATION; MACROPHAGES; MICRORNAS; PLAQUE RUPTURE; SHEAR STRESS;

ANIMALS; ATHEROSCLEROSIS; BIOMECHANICAL PHENOMENA; FIBROSIS; HEMODYNAMICS; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MECHANOTRANSDUCTION, CELLULAR; MICRORNAS; NECROSIS; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; REGIONAL BLOOD FLOW; RUPTURE, SPONTANEOUS; STRESS, MECHANICAL;

EID: 84879964763     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt097     Document Type: Review

References (106)

1. Davies MJ, Thomas AC. Plaque fissuring-The cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-373 (Pubitemid 15055510)
2. Davies MJ. Stability and instability: Two faces of coronary atherosclerosis: The Paul Dudley White Lecture 1995. Circulation 1996;94:2013-2020 (Pubitemid 26349317)
3. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, InsullWet al. A Definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis?: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15: 1512-1531
4. Virmani R, Kolodgie FD, BurkeAP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275 (Pubitemid 30262927)
5. StoneGW, Maehara A, Lansky AJ, De Bruyne B, Cristea E, Mintz GS et al.Aprospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-235
6. Kolodgie FD, Narula J, Burke AP, Haider N, Farb A, Hui-Liang Y et al. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol 2000;157:1259-1268
7. Fishbein MC. The vulnerable and unstable atherosclerotic plaque. Cardiovasc Pathol 2010;19:6-11
8. Caro CG, Fitz-Gerald JM, Schroter RC. Atheroma and arterial wall shear. Observation, correlation and proposal of a shear dependent mass transfer mechanism for atherogenesis. Proc R Soc Lond 1971;177:109-159
9. Giannoglou GD, Antoniadis AP, Koskinas KC, Chatzizisis YS. Flow and atherosclerosis in coronary bifurcations. EuroInterv Suppl 2010;6:16-23
10. Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, Medoff BD et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999;85:199-207 (Pubitemid 29343319)
11. Hsiai TK, Cho SK,Wong PK, Ing M, Salazar A, SevanianAet al. Monocyte recruitment to endothelial cells in response to oscillatory shear stress. FASEB J 2003;17:1648-1657 (Pubitemid 37100066)
12. Matlung HL, Neele AE, Groen HC, Van Gaalen K, Tuna BG, VanWeert A et al. Transglutaminase activity regulates atherosclerotic plaque composition at locations exposed to oscillatory shear stress. Atherosclerosis 2012;224:355-362
13. Williams KJ, Tabas I. The response-To-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15:551-561
14. Djuranovic S, Nahvi A, Green R.Aparsimonious model for gene regulation bymiRNAs. Science 2011;331:550-553
15. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 2008;105:1516-1521 (Pubitemid 351346546)
16. Suárez Y,Wang C, Manes TD, Pober JS. Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: Feedback control of inflammation. J Immunol 2010;184:21-25
17. Zhou J, Wang K-C, Wu W, Subramaniam S, Shyy JY-J, Chiu J-J et al. MicroRNA-21 targets peroxisome proliferators-Activated receptor-Alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci USA 2011; 108:10355-10360
18. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci USA 2010;107:13450-13455
19. Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X et al. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 2011;215:286-293
20. Sun X, Icli B, Wara AK, Belkin N, He S, Kobzik L et al. MicroRNA-181b regulates NF-kB-mediated vascular inflammation. J Clin Inves 2012;122:1973-1990
21. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003;19:71-82 (Pubitemid 36859902)
22. Zawada AM, Rogacev KS, Schirmer SH, Sester M, BöhmM, FliserDet al. Monocyte heterogeneity in human cardiovascular disease. Immunobiology 2012;217:1284-1273
23. Gautier EL, Jakubzick C, Randolph GJ. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler Thromb Vasc Biol 2009;29:1412-1418
24. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R et al. Ly-6Chi monocytes dominate hypercholesterolemia-Associated monocytosis and give rise to macrophages in atheromata. J Clin Inves 2007;117:195-205 (Pubitemid 46048466)
25. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J et al.Monocyte subsets differentially employCCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Inves 2007;117:185-194 (Pubitemid 46048465)
26. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007; 317:666-670 (Pubitemid 47229966)
27. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo J-L et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007;204:3037-3047 (Pubitemid 350179569)
28. Forrest ARR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y et al. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 2010;24: 460-466
29. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007;9:775-787 (Pubitemid 47019464)
30. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, KalwaniMet al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011; 208:1189-1201
31. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat Immunol 2010;11:889-896.
32. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25: 677-686 (Pubitemid 39457982)
33. Cheng C, Tempel D, Van Haperen R, Van Der Baan A, Grosveld F, Daemen MJAP et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006;113:2744-2753 (Pubitemid 43947992)
34. Cheng C, Tempel D, Van Haperen R, De Boer HC, Segers D, Huisman M et al. Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. J Clin Inves 2007;117:616-626 (Pubitemid 46348520)
35. Cuhlmann S, Van der Heiden K, Saliba D, Tremoleda JL, Khalil M, Zakkar M et al. Disturbed blood flow induces RelA expression via c-Jun N-Terminal Kinase 1: A novel mode of NF-{kappa}B regulation that promotes arterial inflammation. Circ Res 2011; 108:950-959
36. Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, Foxwell B et al. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci USA 2004; 101:5634-5639 (Pubitemid 38481208)
37. Gordon S, Martinez FO. Alternative activation of macrophages: Mechanism and functions. Immunity 2010;32:593-604
38. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002;2: 725-734
39. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci USA 2009;106:14978-14983
40. Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston A-T, Clement Met al. Macrophage plasticity in experimental atherosclerosis. Fritz JH, ed. PLoS ONE 2010;5: E8852
41. Stöger JL, Gijbels MJJ, Van der Velden S, Manca M, Van der Loos CM, Biessen EAL et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 2012;225:461-468
42. Taganov KD, Boldin MP, Chang K-J, Baltimore D. NF-kappaB-Dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006;103:12481-12486 (Pubitemid 44267285)
43. Liu G, Friggeri A, Yang Y, Park Y-J, Tsuruta Y, Abraham E. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA 2009;106:15819-15824
44. Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen RR et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Inves 2012;122:4190-4202
45. Donners MMPC,Wolfs IMJ, Stöger LJ, Van der Vorst EPC, Pöttgens CCH, Heymans S et al. Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice. PloS one 2012;7:e35877
46. Greaves DR, Gordon S. The macrophage scavenger receptor at 30 years of age: Current knowledge and future challenges. J Lipid Res 2009;50(suppl.):S282- S286
47. Huang R, Hu G, Lin B, Lin Z, Sun C. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-Density lipoprotein-stimulated human THP-1 macrophages. J Inves Med Am Fed Clin Res 2010;58:961-967
48. Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDLstimulated monocyte/macrophages. Cardiovasc Res 2009;83:131-139
49. Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu J et al. MiR-146a inhibits oxidized low-Density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett 2011;585:854-860
50. Liu J,Huan C, Chakraborty M, ZhangH, LuD, Kuo M-S et al. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice. Circ Res 2009;105:295-303
51. Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010;328: 1570-1573
52. Marquart TJ, Allen RM, OryDS, BaldánA. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 2010;107:12228-12232
53. Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, Van Gils JM et al. Inhibition of miR-33a/b in non-human primates raises plasmaHDLand lowersVLDLtriglycerides. Nature 2011;478:404-407
54. Glagov S,Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. New Engl J Med 1987;316: 1371-1375 (Pubitemid 17079680)
55. Koskinas KC, Chatzizisis YS, Baker AB, Edelman ER, Stone PH, Feldman CL. The role of low endothelial shear stress in the conversion of atherosclerotic lesions from stable to unstable plaque. Curr Opin Cardiol 2009;24:580-590
56. Gambillara V, Montorzi G, Haziza-Pigeon C, Stergiopulos N, Silacci P. Arterial wall response to ex vivo exposure to oscillatory shear stress. J Vasc Res 2005;42:535-544 (Pubitemid 41527609)
57. Ohayon J, Finet G, Gharib AM, Herzka DA, Tracqui P, Heroux J et al. Necrotic core thickness and positive arterial remodeling index: Emergent biomechanical factors for evaluating the risk of plaque rupture. Am J Physiol Heart Circ Physiol 2008;295: H717-H727
58. Okura H, Kobayashi Y, Sumitsuji S, Terashima M, Kataoka T, Masutani M et al. Effect of culprit-lesion remodeling versus plaque rupture on three-year outcome in patients with acute coronary syndrome. Am J Cardiol 2009;103:791-795
59. Chatzizisis YS, Jonas M, Coskun AU, Beigel R, Stone BV, Maynard C et al. Prediction of the localization of high-risk coronary atherosclerotic plaques on the basis of low endothelial shear stress: An intravascular ultrasound and histopathology natural history study. Circulation 2008;117:993-1002
60. Thacher TN, Gambillara V, Riche F, Silacci P, Stergiopulos N, Da Silva RF. Regulation of arginase pathway in response to wall shear stress. Atherosclerosis 2010;210:63-70
61. Haga M, Yamashita A, Paszkowiak J, Sumpio BE, Dardik A. Oscillatory shear stress increases smooth muscle cell proliferation and Akt phosphorylation. J Vasc Surg 2003;37:1277-1284 (Pubitemid 41123106)
62. Deguchi J-O, Aikawa E, Libby P, Vachon JR, Inada M, Krane SM et al. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 2005;112:2708-2715 (Pubitemid 41532609)
63. Kadl A, Meher AK, Sharma PR, LeeMY, DoranAC, Johnstone SR et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 2010;107:737-746
64. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, HafnerGet al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003;107:1579-1585 (Pubitemid 36397324)
65. Rutnam ZJ, Wight TN, Yang BB. miRNAs regulate expression and function of extracellular matrix molecules. Matrix Biol 2013;32:74-85
66. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102: 13944-13949 (Pubitemid 41377683)
67. Seimon T, Tabas I. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J Lipid Res 2009;50(suppl.):S382-S387
68. Cai Q, Lanting L, Natarajan R. Interaction of monocytes with vascular smooth muscle cells regulates monocyte survival and differentiation through distinct pathways. Arterioscler Thromb Vasc Biol 2004;24:2263-2270 (Pubitemid 39658027)
69. Guo M, Mao X, Ji Q, Lang M, Li S, Peng Y et al. miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Immunol Cell Biol 2010;88:555-564
70. Hulsmans M, Van Dooren E, Mathieu C, Holvoet P. Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin. PloS one 2012;7:e32794
71. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-977 (Pubitemid 13080473)
72. Xia H, Qi Y, Ng SS, Chen X, Li D, Chen S et al. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res 2009;1269:158-165
73. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009;55:1944-1949
74. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG et al. Circulating microRNAs are newand sensitive biomarkers of myocardial infarction. Eur Heart J 2010;31:2765-2773
75. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010;107:677-684
76. Stanczyk J, Pedrioli DML, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthr Rheumat 2008;58:1001-1009 (Pubitemid 351564001)
77. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, ProkopiMet al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107:810-817
78. Van Bochove GS, Straathof R, Krams R, Nicolay K, Strijkers GJ. MRI-Determined carotid artery flow velocities and wall shear stress in a mouse model of vulnerable and stable atherosclerotic plaque. MAGMA 2010;23:77-84
79. Cheng C, Tempel D, van Haperen R, vanDammeL, AlgurM, KramsRet al. Activation of MMP8andMMP13by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdownin atherosclerotic lesions with a vulnerable phenotype. Atherosclerosis 2009;204:26-33
80. Gijsen FJH,Wentzel JJ, Thury A, Mastik F, Schaar JA, Schuurbiers JCH et al. Strain distribution over plaques in human coronary arteries relates to shear stress. Am J Physiol Heart Circ Physiol 2008;295:H1608-H1614
81. Dirksen MT, Van DerWal AC, Van Den Berg FM, Van Der Loos CM, Becker AE. Distribution of inflammatory cells in atherosclerotic plaques relates to the direction of flow. Circulation 1998;98:2000-2003 (Pubitemid 28512223)
82. Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T et al. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989;161:859-864 (Pubitemid 19162713)
83. Tricot O, Mallat Z, Heymes C, Belmin J, Lesèche G, Tedgui A. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 2000;101:2450-2453 (Pubitemid 30366245)
84. Yilmaz A, Lipfert B, Cicha I, Schubert K, Klein M, Raithel D et al. Accumulation of immune cells and high expression of chemokines/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques. Exp Mol Pathol 2007;82:245-255 (Pubitemid 46686659)
85. Nomura S, Tandon NN, Nakamura T, Cone J, Fukuhara S, Kambayashi J. High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis 2001;158: 277-287 (Pubitemid 32913636)
86. Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004;176: 101-110 (Pubitemid 39078651)
87. Segers D, Helderman F, Cheng C, Van Damme LCA, Tempel D, Boersma E et al. Gelatinolytic activity in atherosclerotic plaques is highly localized and is associated with both macrophages and smooth muscle cells in vivo. Circulation 2007;115:609-616 (Pubitemid 46226171)
88. Galis ZS, Sukhova GK, LarkMW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Inves 1994;94:2493-2503 (Pubitemid 24379627)
89. OhayonJ, Dubreuil O, Tracqui P, Le Floc'h S, Rioufol G,Chalabreysse L et al. Influence of residual stress/strain on the biomechanical stability of vulnerable coronary plaques: Potential impact for evaluating the risk of plaque rupture. Am J Physiol Heart Circ Physiol 2007;293:H1987-H1996 (Pubitemid 47370971)
90. Samady H, Eshtehardi P, McDaniel MC, Suo J, Dhawan SS, Maynard C et al. Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery disease. Circulation 2011;124:779-788
91. Teng Z, Canton G, Yuan C, Ferguson M, Yang C, Huang X et al. 3D critical plaque wall stress is a better predictor of carotid plaque rupture sites than flow shear stress: An in vivo MRI-based 3D FSI study. J Biomech Eng 2010;132:031007
92. Gao H, Long Q, Kumar Das S, Halls J, Graves M, Gillard JH et al. Study of carotid arterial plaque stress for symptomatic and asymptomatic patients. J Biomech 2011;44: 2551-2557
93. Teng Z, Sadat U, Ji G, Zhu C, Young VE, Graves MJ et al. Lumen irregularity dominates the relationship between mechanical stress condition, fibrous-cap thickness, and lumen curvature in carotid atherosclerotic plaque. J Biomech Eng 2011;133:034501
94. Jarrett BR, Correa C, Ma KL, Louie AY. In vivo mapping of vascular inflammation using multimodal imaging. PloS one 2010;5:e13254
95. Gao T, He X, YuW, ZhangZ,Wang Y. Atherosclerotic plaque pathohistology and classification with high-resolution MRI. Neurol Res 2011;33:325-330
96. Geissmann F,Gordon S,HumeDA,MowatAM,Randolph GJ. Unravellingmononuclear phagocyte heterogeneity. Nat Rev Immunol 2010;10:453-460
97. Weber M, Baker MB, Moore JP, Searles CD. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 2010;393:643-648
98. Lu L-F, Thai T-H, Calado DP, Chaudhry A, Kubo M, Tanaka K et al. Foxp3-Dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009;30:80-91
99. Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci USA 2010;107:17321-17326
100. Cheng C, Van Haperen R, DeWaard M, Van Damme LCA, Tempel D, Hanemaaijer L et al. Shear stress affects the intracellular distribution of eNOS: Direct demonstration by a novel in vivo technique. Blood 2005;106:3691-3698 (Pubitemid 41739002)
101. HochleitnerBW,Hochleitner EO, ObristP, EberlT, Amberger A,XuQet al. Fluid shear stress induces heat shock protein 60 expression in endothelial cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 2000;20:617-623 (Pubitemid 30151672)
102. Phinikaridou A, Hua N, Pham T, Hamilton JA. Regions of low endothelial shear stress co-localize with positive vascular remodeling and atherosclerotic plaque disruption: An in vivo MRI study. Circ Cardiovasc Imag 2013;6:302-310
103. Debernardi N, Roijers RB, Krams R,DeCromR, Mutsaers PH, Vander Vusse GJ. Microcalcifications in atherosclerotic lesion of apolipoprotein E-Deficient mouse. Int J Exp Pathol 2010;91:485-494
104. Hwang J, Ing MH, Salazar A, Lassègue B, Griendling K, Navab M et al. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: Implication for native LDL oxidation. Circ Res 2003;93:1225-1232 (Pubitemid 37543063)
105. Willett NJ, Kundu K, Knight SF, Dikalov S, Murthy N, TaylorWR. Redox signaling in an in vivo murine model of low magnitude oscillatory wall shear stress. Antioxidant Red Signal 2011;15:1369-1378
106. Ni C-W, Qiu H, Jo H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol 2011; 300:H1762-H1769 London